| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Clowes Howard serves as a Director at PSTV and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 7 buys and 0 sells. Those positions are worth an estimated $35K at current prices.
Historically, Clowes Howard's trades have earned a below-average insider score of 31/100 across 6 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -46.5%.
The biggest single holding is PSTV (~$35K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 43,297 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2024 | PSTV Plus Therapeutics, Inc. | Director | Buy | 5,000 | $1.34 | $6,681.00 | +23.3% | -3.3% | -65.2% | |
| May 8, 2024 | PSTV Plus Therapeutics, Inc. | Director | Buy | 9,804 | $2.04 | $20,000.16 | +83.8% | -29.5% | -72.7% | |
| Sep 13, 2023 | PSTV Plus Therapeutics, Inc. | Director | Buy | 6,993 | $1.43 | $10,021.67 | +148.8% | +49.7% | 0.0% | |
| Jun 6, 2023 | PSTV Plus Therapeutics, Inc. | Director | Buy | 1,000 | $3.98 | $3,980.00 | +27.0% | -27.4% | -35.4% | |
| May 3, 2023 | PSTV Plus Therapeutics, Inc. | Director | Buy | 2,500 | $3.64 | $9,101.50 | +208.3% | -33.3% | -52.0% | |
| Jun 2, 2022 | PSTV Plus Therapeutics, Inc. | Director | Buy | 15,000 | $0.57 | $8,589.00 | +500.0% | +48.8% | -53.5% | |
| Mar 3, 2021 | PSTV Plus Therapeutics, Inc. | Director | Buy | 3,000 | $2.42 | $7,260.00 | New | - | - |